Neuberger Berman Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Neuberger Berman Group’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$240K	Buy	+5,712	New	+$182K	﹤0.01%	2106
2022 Q2	–	Sell	-28,708	Closed	-$1.32M	–	1856
2022 Q1	$1.32M	Sell	28,708 -4,620	-14%	-$220K	﹤0.01%	1284
2021 Q4	$2.04M	Buy	+33,328	New	+$2.3M	﹤0.01%	1188
2021 Q3	–	Sell	-2,376	Closed	-$220K	–	1762
2021 Q2	$220K	Buy	+2,376	New	+$202K	﹤0.01%	1690

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Neuberger Berman Group's ARKG Position: Q2 2026 in Review

Neuberger Berman Group opened a new position in ARK Genomic Revolution ETF (ARKG) in Q2 2026: 5,712 shares worth $240K. The stake represents ﹤0.01% of the portfolio and ranks #2106 among its holdings. This is a return to the name: Neuberger Berman Group previously reported a position in ARKG as recently as Q1 2022.

Neuberger Berman Group first reported a position in ARKG in Q2 2021 and has held it in 4 quarters since. The position peaked at $2.04M in Q4 2021. 272 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Neuberger Berman Group held 5,712 shares of ARK Genomic Revolution ETF worth $240K as of Q2 2026.
ARK Genomic Revolution ETF was a new Neuberger Berman Group position in Q2 2026.
ARK Genomic Revolution ETF made up ﹤0.01% of Neuberger Berman Group's portfolio in Q2 2026, its #2106 holding.
Neuberger Berman Group first reported a position in ARK Genomic Revolution ETF in Q2 2021 and has held it in 4 quarters since.
Neuberger Berman Group's ARK Genomic Revolution ETF position peaked at $2.04M in Q4 2021.
272 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.